Pathologic Myopia 2nd ed. 2021 Edition

Pathologic Myopia is a major cause of severe vision loss worldwide. The mechanisms for vision loss include cataract, glaucoma, retinal detachment, and above all, myopic maculopathy within the posterior staphyloma. The first edition of Pathologic Myopia is one of the only current books to specifically address this disease and discusses recent developments in imaging technologies and various approaches to treatments, such as laser photocoagulation, photodynamic therapy, pharmaco-therapeutic injections in the vitreous, and surgery. 

This new edition is a timely update to the standard reference in the field, with new chapters on advanced refractive error correction, genetics, developing a classification system, and special surgical approaches for pathologic myopia. Complete with even more high-quality color images and informative tables, this book is written and edited by leaders in the field and is geared towards ophthalmologists, including residents and fellows in training, glaucoma and cataract specialists, and vitreoretinal macula experts.

Richard F. Spaide, MD

Vitreous, Retina, Macula Consultants of New York

rick.spaide@gmail.com 

Kyoko Ohno-Matsui

Department of Ophthalmology and Visual Science

Tokyo Medical and Dental University

k.ohno.oph@tmd.ac.jp

Lawrence A. Yannuzzi, MD

Professor of Clinical Ophthalmology

College of Physicians and Surgeons

Columbia University

Founder, Director and President of The Macula Foundation, Inc. 

New York, NY, USA 

layannuzzi@gmail.com